Want to join the conversation?
$CAH said Pharmaceutical segment revenue in 4Q16 grew 14% to $28.2Bil, driven by growth from existing and net new pharmaceutical distribution customers and performance from the Specialty business. Segment profit increased 1% to $542MM primarily due to contributions from acquisitions.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.